Related Experiment Video
Updated: Jul 19, 2025

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4
Xuzichao Li1, Fumeng Liao1, Jiaqi Gao1
1State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Haihe Laboratory of Cell Ecosystem, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Abstract:
CRISPR-Cas systems act as the adaptive immune systems of bacteria and archaea, targeting and destroying invading foreign mobile genetic elements (MGEs) such as phages. MGEs have also evolved anti-CRISPR (Acr) proteins to inactivate the CRISPR-Cas systems. Recently, AcrIIC4, identified from Haemophilus parainfluenzae phage, has been reported to inhibit the endonuclease activity of Cas9 from Neisseria meningitidis (NmeCas9), but the inhibition mechanism is not clear. Here, we biochemically and structurally investigated the anti-CRISPR activity of AcrIIC4. AcrIIC4 folds into a helix bundle composed of three helices, which associates with the REC lobe of NmeCas9 and sgRNA. The REC2 domain of NmeCas9 is locked by AcrIIC4, perturbing the conformational dynamics required for the target DNA binding and cleavage. Furthermore, mutation of the key residues in the AcrIIC4-NmeCas9 and AcrIIC4-sgRNA interfaces largely abolishes the inhibitory effects of AcrIIC4. Our study offers new insights into the mechanism of AcrIIC4-mediated suppression of NmeCas9 and provides guidelines for the design of regulatory tools for Cas9-based gene editing applications.
Insights
Anti-CRISPR protein AcrIIC4 inhibits Neisseria meningitidis Cas9 (NmeCas9) by locking its REC2 domain, preventing DNA binding and cleavage. This discovery offers insights into CRISPR-Cas regulation and gene editing tool development.
Area of Science:
- Molecular Biology
- Microbial Immunity
- Structural Biology
Background:
- CRISPR-Cas systems provide adaptive immunity in prokaryotes against foreign genetic elements.
- Anti-CRISPR (Acr) proteins are viral factors that counteract CRISPR-Cas activity.
- The inhibition mechanism of AcrIIC4 on Neisseria meningitidis Cas9 (NmeCas9) was previously unclear.
Purpose of the Study:
- To biochemically and structurally elucidate the anti-CRISPR mechanism of AcrIIC4 against NmeCas9.
- To understand how AcrIIC4 interacts with NmeCas9 and sgRNA.
- To provide a basis for developing regulatory tools for Cas9 gene editing.
Main Methods:
- Biochemical assays to assess inhibitory activity.
- Structural studies (likely crystallography or cryo-EM) to determine complex structure.
- Site-directed mutagenesis to identify key interaction residues.
Main Results:
- AcrIIC4 forms a helix bundle that binds to the REC lobe of NmeCas9 and sgRNA.
- AcrIIC4 locks the REC2 domain of NmeCas9, disrupting DNA binding and cleavage.
- Mutations at the AcrIIC4-NmeCas9 or AcrIIC4-sgRNA interfaces significantly reduce inhibition.
Conclusions:
- AcrIIC4 inhibits NmeCas9 by a novel mechanism involving conformational locking of the REC2 domain.
- The findings clarify the molecular basis of AcrIIC4-mediated NmeCas9 suppression.
- This research informs the engineering of controllable Cas9-based gene editing technologies.
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
The Antiviral System of Bacteria and Archaea: CRISPR
Experimental RNAi
Homologous Recombination

